563 Results

People

  1. Zelenetz
    Zelenetz
  2. Moskowitz
    Moskowitz
  3. Yahalom
    Yahalom
  4. Noy
    Noy
  5. De Angelis
    De Angelis
  6. Perales
    Perales
  7. Abrey
    Abrey
  8. Palomba
    Palomba
  9. Younes
    Younes
  10. Matasar
    Matasar

Groups

  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)
  7. Bone Marrow Transplant (65)
  8. GSK Faculty (60)
  9. Epidemiology and Biostatistics (58)
  10. Adult Leukemia (53)
  1. "rituximab"
Formats
  1. Journal Article (489)
  2. Review (36)
  3. Research Letter (13)
  4. Editorial (9)
  5. Correspondence (6)
  6. Meeting Abstract (4)
  7. Book Section (2)
  8. Conference Paper (2)
  9. Guidelines (2)
Groups
  1. Department of Medicine (377)
  2. Hematologic Malignancies, Division of (338)
  3. Center for Hematologic Malignancies (292)
  4. Lymphoma (192)
  5. Survivorship Research (98)
  6. Tow Center for Developmental Oncology (TCDO) (72)

More Groups

People
  1. Andrew Zelenetz (87)
  2. Craig Moskowitz (52)
  3. Joachim Yahalom (39)
  4. Ariela Noy (35)
  5. Lisa De Angelis (32)
  6. Paul Hamlin (32)

More People

Years
  1. 2025 (21)
  2. 2024 (36)
  3. 2023 (36)
  4. 2022 (28)
  5. 2021 (14)
  6. 2020 (25)

More Years

Publications
  1. Blood (43)
  2. Leukemia and Lymphoma (38)
  3. Journal of Clinical Oncology (32)
  4. Haematologica (21)
  5. British Journal of Haematology (20)
  6. Journal of the National Comprehensive Cancer Network (16)

More Publications

Publishers
  1. Elsevier Inc. (70)
  2. American Society of Hematology (61)
  3. Taylor & Francis Group (44)
  4. Springer (42)
  5. American Society of Clinical Oncology (36)
  6. Nature Publishing Group (28)

More Publishers

Results (563)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy
    Review

    Bachanova, V.; Perales, M. A.; Abramson, J. S.
    Blood Reviews (2020)

    Fulltext@MSK | Save
  • Isolation of a novel intertypic recombinant human mastadenovirus B2 from two unrelated bone marrow transplant recipients
    Journal Article

    Kajon, A. E.; Lamson, D. M.; Spiridakis, E.; Cardenas, A. M.; Babady, N. E.; Fisher, B. T.; St George, K.
    New Microbes and New Infections (2020)

    Fulltext@MSK | Save
  • Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
    Journal Article

    Nakajima, R.; Moskowitz, A. J.; Michaud, L.; Mauguen, A.; Batlevi, C. L.; Dogan, A.; Schöder, H.
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Acalabrutinib and its therapeutic potential in the treatment of chronic lymphocytic leukemia: A short review on emerging data
    Review

    Isaac, K.; Mato, A. R.
    Cancer Management and Research (2020)

    Fulltext@MSK | Save
  • Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody
    Journal Article

    Sarlo, K. M.; Dixon, B. N.; Ni, A.; Straus, D. J.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Clonally-related CD5+ CLL/SLL and CD10+ high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications
    Journal Article

    Kumar, P.; Uppal, M.; Xiao, W.; Dogan, A.; Roshal, M.; Gao, Q.; Aypar, U.; Zhang, Y.; Arcila, M. E.; Moung, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study
    Journal Article

    Cortazar, F. B.; Kibbelaar, Z. A.; Glezerman, I. G.; Abudayyeh, A.; Mamlouk, O.; Motwani, S. S.; Murakami, N.; Herrmann, S. M.; Manohar, S.; Shirali, A. C.; more...
    Journal of the American Society of Nephrology (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
    Journal Article

    Sehn, L. H.; Herrera, A. F.; Flowers, C. R.; Kamdar, M. K.; McMillan, A.; Hertzberg, M.; Assouline, S.; Kim, T. M.; Kim, W. S.; Ozcan, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • RECIL versus lugano for treatment response assessment in FDG-avid non-Hodgkin lymphomas: A head-to-head comparison in 54 patients
    Journal Article

    Berzaczy, D.; Haug, A.; Staber, P. B.; Raderer, M.; Kiesewetter, B.; Jaeger, U.; Kornauth, C.; Simonitsch-Klupp, I.; Mayerhoefer, M. E.
    Cancers (2020)

    Fulltext@MSK | Save